Vericel (VCEL) Stock Highlights

57.26 | +2.56%

2024-11-21 02:36:51

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

Statistics

Range Today

55.33 57.34

Volume Today 335.7K

Range 1 Year

32.31 57.81

Volume 1 Year 106.36M

Range 3 Year

17.3 57.81

Volume 3 Year 318.35M

Range 10 Year

1.69 68.94

Volume 10 Year 1.36B

Highlights

Market Capitalization 2.67B (mid)

Floating Shares 48.56M

Current Price 57.26

Price To Earnings 619.25

Price To Revenue 10.95

Price To Book 11.43

Earnings Per Share 0.08

Payout Ratio 0%

Performance

Latest +2.56%

1 Month +38.64%

3 Months +21.08%

6 Months +18.65%

1 Year +57.87%

3 Years +28.44%

5 Years +211.2%

10 Years +1974.64%

Benchmarks

Market Capitalization

74 / 368

Gross Profits

43 / 278

Total Revenue

62 / 300

Total Rank

55 / 368

Free Cashflow

88 / 352

Performance 5 years

51 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.